nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiludronate—Paget's disease of bone—osteoporosis	0.256	1	CtDrD
Tiludronate—ATP6V1A—Etidronic acid—osteoporosis	0.137	0.591	CbGbCtD
Tiludronate—Diphosphonates—Ibandronate—osteoporosis	0.115	0.248	CiPCiCtD
Tiludronate—ATP6V1A—Alendronate—osteoporosis	0.0948	0.409	CbGbCtD
Tiludronate—Diphosphonates—Pamidronate—osteoporosis	0.0873	0.188	CiPCiCtD
Tiludronate—Diphosphonates—Alendronate—osteoporosis	0.0873	0.188	CiPCiCtD
Tiludronate—Diphosphonates—Risedronate—osteoporosis	0.0873	0.188	CiPCiCtD
Tiludronate—Diphosphonates—Etidronic acid—osteoporosis	0.0873	0.188	CiPCiCtD
Tiludronate—PTPN1—N-cadherin signaling events—GSN—osteoporosis	0.00127	0.0539	CbGpPWpGaD
Tiludronate—PTPN1—Integrin alphaIIb beta3 signaling—TLN1—osteoporosis	0.00112	0.0477	CbGpPWpGaD
Tiludronate—PTPN1—N-cadherin signaling events—LRP5—osteoporosis	0.00111	0.0469	CbGpPWpGaD
Tiludronate—ATP6V1A—Latent infection of Homo sapiens with Mycobacterium tuberculosis—LTF—osteoporosis	0.00106	0.0451	CbGpPWpGaD
Tiludronate—PTPN1—Integrin alphaIIb beta3 signaling—RAP1A—osteoporosis	0.000927	0.0393	CbGpPWpGaD
Tiludronate—PTPN1—Platelet Aggregation (Plug Formation)—TLN1—osteoporosis	0.000874	0.0371	CbGpPWpGaD
Tiludronate—PTPN1—Integrin alphaIIb beta3 signaling—FGA—osteoporosis	0.000841	0.0357	CbGpPWpGaD
Tiludronate—PTPN1—Integrin alphaIIb beta3 signaling—FGB—osteoporosis	0.000765	0.0324	CbGpPWpGaD
Tiludronate—PTPN1—Platelet Aggregation (Plug Formation)—RAP1A—osteoporosis	0.000721	0.0306	CbGpPWpGaD
Tiludronate—PTPN1—Platelet Aggregation (Plug Formation)—FGA—osteoporosis	0.000654	0.0277	CbGpPWpGaD
Tiludronate—PTPN1—Platelet Aggregation (Plug Formation)—FGB—osteoporosis	0.000595	0.0252	CbGpPWpGaD
Tiludronate—PTPN1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—NFATC1—osteoporosis	0.000552	0.0234	CbGpPWpGaD
Tiludronate—Developmental delay—Estradiol—osteoporosis	0.00054	0.022	CcSEcCtD
Tiludronate—Congenital anomaly—Estradiol—osteoporosis	0.00054	0.022	CcSEcCtD
Tiludronate—Influenza-like symptoms—Alendronate—osteoporosis	0.000535	0.0218	CcSEcCtD
Tiludronate—Influenza-like symptoms—Ibandronate—osteoporosis	0.000521	0.0213	CcSEcCtD
Tiludronate—PTPN1—Growth hormone receptor signaling—IRS2—osteoporosis	0.000471	0.02	CbGpPWpGaD
Tiludronate—Bone pain—Etidronic acid—osteoporosis	0.000468	0.0191	CcSEcCtD
Tiludronate—Influenza-like symptoms—Ethinyl Estradiol—osteoporosis	0.00044	0.018	CcSEcCtD
Tiludronate—PTPN1—Insulin Signaling—CAP1—osteoporosis	0.000433	0.0183	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—WDR1—osteoporosis	0.000423	0.0179	CbGpPWpGaD
Tiludronate—PTPN1—Growth hormone receptor signaling—IRS1—osteoporosis	0.000411	0.0174	CbGpPWpGaD
Tiludronate—Influenza-like symptoms—Pamidronate—osteoporosis	0.000408	0.0167	CcSEcCtD
Tiludronate—PTPN1—IGF1 pathway—IRS2—osteoporosis	0.000394	0.0167	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—RAP1A—osteoporosis	0.000389	0.0165	CbGpPWpGaD
Tiludronate—Bone pain—Ibandronate—osteoporosis	0.000389	0.0159	CcSEcCtD
Tiludronate—Bone pain—Calcitriol—osteoporosis	0.00038	0.0155	CcSEcCtD
Tiludronate—Influenza-like symptoms—Zoledronate—osteoporosis	0.000373	0.0152	CcSEcCtD
Tiludronate—Influenza like illness—Alendronate—osteoporosis	0.000371	0.0152	CcSEcCtD
Tiludronate—Influenza like illness—Ibandronate—osteoporosis	0.000361	0.0148	CcSEcCtD
Tiludronate—PTPN1—IGF1 pathway—IRS1—osteoporosis	0.000344	0.0146	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—CAP1—osteoporosis	0.000334	0.0142	CbGpPWpGaD
Tiludronate—Bone pain—Risedronate—osteoporosis	0.00032	0.0131	CcSEcCtD
Tiludronate—PTPN1—IGF1 pathway—IGF1—osteoporosis	0.000318	0.0135	CbGpPWpGaD
Tiludronate—Influenza like illness—Ethinyl Estradiol—osteoporosis	0.000306	0.0125	CcSEcCtD
Tiludronate—Bone pain—Pamidronate—osteoporosis	0.000304	0.0124	CcSEcCtD
Tiludronate—Influenza like illness—Risedronate—osteoporosis	0.000298	0.0122	CcSEcCtD
Tiludronate—Influenza-like symptoms—Estradiol—osteoporosis	0.000287	0.0117	CcSEcCtD
Tiludronate—Influenza like illness—Pamidronate—osteoporosis	0.000283	0.0116	CcSEcCtD
Tiludronate—Bone pain—Zoledronate—osteoporosis	0.000278	0.0113	CcSEcCtD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—RAP1A—osteoporosis	0.000272	0.0115	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—MGLL—osteoporosis	0.000265	0.0113	CbGpPWpGaD
Tiludronate—Influenza like illness—Zoledronate—osteoporosis	0.000259	0.0106	CcSEcCtD
Tiludronate—PTPN1—Insulin Pathway—IRS1—osteoporosis	0.000248	0.0105	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by PTP1B—LEP—osteoporosis	0.000248	0.0105	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—PLEK—osteoporosis	0.000243	0.0103	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by PTP1B—IRS1—osteoporosis	0.000221	0.00939	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—WDR1—osteoporosis	0.000218	0.00924	CbGpPWpGaD
Tiludronate—Bone pain—Estradiol—osteoporosis	0.000214	0.00874	CcSEcCtD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—TLN1—osteoporosis	0.000209	0.00887	CbGpPWpGaD
Tiludronate—Pain—Calcium Acetate—osteoporosis	0.000209	0.00851	CcSEcCtD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—VCL—osteoporosis	0.000206	0.00875	CbGpPWpGaD
Tiludronate—Influenza like illness—Estradiol—osteoporosis	0.000199	0.00813	CcSEcCtD
Tiludronate—Rhinitis—Estropipate—osteoporosis	0.000195	0.00797	CcSEcCtD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—KL—osteoporosis	0.000195	0.00826	CbGpPWpGaD
Tiludronate—Rhinitis—Raloxifene—osteoporosis	0.000189	0.00772	CcSEcCtD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IRAK3—osteoporosis	0.000187	0.00792	CbGpPWpGaD
Tiludronate—PTPN1—Leptin signaling pathway—LEP—osteoporosis	0.000185	0.00785	CbGpPWpGaD
Tiludronate—Pain—Ergocalciferol—osteoporosis	0.000184	0.00752	CcSEcCtD
Tiludronate—PTPN1—Leptin signaling pathway—ESR1—osteoporosis	0.000177	0.00749	CbGpPWpGaD
Tiludronate—Asthenia—Calcium Acetate—osteoporosis	0.000175	0.00714	CcSEcCtD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	0.000172	0.00731	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—CAP1—osteoporosis	0.000172	0.0073	CbGpPWpGaD
Tiludronate—Arthralgia—Etidronic acid—osteoporosis	0.000167	0.00681	CcSEcCtD
Tiludronate—Diarrhoea—Calcium Acetate—osteoporosis	0.000167	0.00681	CcSEcCtD
Tiludronate—PTPN1—Leptin signaling pathway—IRS1—osteoporosis	0.000165	0.007	CbGpPWpGaD
Tiludronate—Back pain—Estropipate—osteoporosis	0.000164	0.0067	CcSEcCtD
Tiludronate—Dizziness—Calcium Acetate—osteoporosis	0.000161	0.00658	CcSEcCtD
Tiludronate—Rhinitis—Ethinyl Estradiol—osteoporosis	0.000158	0.00646	CcSEcCtD
Tiludronate—Back pain—Ibandronate—osteoporosis	0.000157	0.00642	CcSEcCtD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—FGA—osteoporosis	0.000156	0.00663	CbGpPWpGaD
Tiludronate—Asthenia—Ergocalciferol—osteoporosis	0.000155	0.00631	CcSEcCtD
Tiludronate—Rhinitis—Risedronate—osteoporosis	0.000154	0.0063	CcSEcCtD
Tiludronate—Vertigo—Estropipate—osteoporosis	0.000152	0.00622	CcSEcCtD
Tiludronate—Vertigo—Alendronate—osteoporosis	0.00015	0.00613	CcSEcCtD
Tiludronate—Vertigo—Raloxifene—osteoporosis	0.000148	0.00603	CcSEcCtD
Tiludronate—Rhinitis—Pamidronate—osteoporosis	0.000147	0.00599	CcSEcCtD
Tiludronate—Vertigo—Ibandronate—osteoporosis	0.000146	0.00597	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Etidronic acid—osteoporosis	0.000146	0.00595	CcSEcCtD
Tiludronate—Nausea—Calcium Acetate—osteoporosis	0.000145	0.00591	CcSEcCtD
Tiludronate—Myalgia—Estropipate—osteoporosis	0.000144	0.00589	CcSEcCtD
Tiludronate—Arthralgia—Estropipate—osteoporosis	0.000144	0.00589	CcSEcCtD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—FGB—osteoporosis	0.000142	0.00603	CbGpPWpGaD
Tiludronate—Myalgia—Alendronate—osteoporosis	0.000142	0.00581	CcSEcCtD
Tiludronate—Dyspepsia—Etidronic acid—osteoporosis	0.000141	0.00575	CcSEcCtD
Tiludronate—Myalgia—Raloxifene—osteoporosis	0.00014	0.00571	CcSEcCtD
Tiludronate—Arthralgia—Raloxifene—osteoporosis	0.00014	0.00571	CcSEcCtD
Tiludronate—Myalgia—Ibandronate—osteoporosis	0.000139	0.00565	CcSEcCtD
Tiludronate—Arthralgia—Ibandronate—osteoporosis	0.000139	0.00565	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—MGLL—osteoporosis	0.000137	0.0058	CbGpPWpGaD
Tiludronate—Myalgia—Calcitriol—osteoporosis	0.000136	0.00553	CcSEcCtD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—IRS2—osteoporosis	0.000133	0.00566	CbGpPWpGaD
Tiludronate—Back pain—Ethinyl Estradiol—osteoporosis	0.000133	0.00543	CcSEcCtD
Tiludronate—Gastrointestinal pain—Etidronic acid—osteoporosis	0.000131	0.00534	CcSEcCtD
Tiludronate—Back pain—Risedronate—osteoporosis	0.00013	0.00529	CcSEcCtD
Tiludronate—Rhinitis—Conjugated Estrogens—osteoporosis	0.000129	0.00527	CcSEcCtD
Tiludronate—Nausea—Ergocalciferol—osteoporosis	0.000128	0.00522	CcSEcCtD
Tiludronate—Abdominal pain—Etidronic acid—osteoporosis	0.000127	0.00516	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Estropipate—osteoporosis	0.000126	0.00515	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—ANXA2—osteoporosis	0.000125	0.00531	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PLEK—osteoporosis	0.000125	0.00531	CbGpPWpGaD
Tiludronate—Musculoskeletal discomfort—Alendronate—osteoporosis	0.000124	0.00507	CcSEcCtD
Tiludronate—Back pain—Pamidronate—osteoporosis	0.000123	0.00503	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.000122	0.00499	CcSEcCtD
Tiludronate—Dyspepsia—Estropipate—osteoporosis	0.000122	0.00497	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.000121	0.00494	CcSEcCtD
Tiludronate—Vertigo—Risedronate—osteoporosis	0.00012	0.00492	CcSEcCtD
Tiludronate—Dyspepsia—Alendronate—osteoporosis	0.00012	0.0049	CcSEcCtD
Tiludronate—PTPN1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—osteoporosis	0.000118	0.00502	CbGpPWpGaD
Tiludronate—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.000118	0.00483	CcSEcCtD
Tiludronate—Pain—Estropipate—osteoporosis	0.000118	0.00483	CcSEcCtD
Tiludronate—Dyspepsia—Raloxifene—osteoporosis	0.000118	0.00482	CcSEcCtD
Tiludronate—PTPN1—Leptin signaling pathway—IL1B—osteoporosis	0.000118	0.005	CbGpPWpGaD
Tiludronate—Dyspepsia—Ibandronate—osteoporosis	0.000117	0.00477	CcSEcCtD
Tiludronate—Pain—Alendronate—osteoporosis	0.000117	0.00476	CcSEcCtD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—IRS1—osteoporosis	0.000116	0.00494	CbGpPWpGaD
Tiludronate—Pain—Raloxifene—osteoporosis	0.000115	0.00468	CcSEcCtD
Tiludronate—Myalgia—Risedronate—osteoporosis	0.000114	0.00466	CcSEcCtD
Tiludronate—Arthralgia—Risedronate—osteoporosis	0.000114	0.00466	CcSEcCtD
Tiludronate—Pain—Ibandronate—osteoporosis	0.000114	0.00463	CcSEcCtD
Tiludronate—Gastrointestinal pain—Estropipate—osteoporosis	0.000113	0.00462	CcSEcCtD
Tiludronate—Back pain—Zoledronate—osteoporosis	0.000113	0.0046	CcSEcCtD
Tiludronate—Gastrointestinal pain—Alendronate—osteoporosis	0.000112	0.00455	CcSEcCtD
Tiludronate—Pain—Calcitriol—osteoporosis	0.000111	0.00454	CcSEcCtD
Tiludronate—Gastrointestinal pain—Raloxifene—osteoporosis	0.00011	0.00448	CcSEcCtD
Tiludronate—Diarrhoea—Etidronic acid—osteoporosis	0.00011	0.00447	CcSEcCtD
Tiludronate—Abdominal pain—Estropipate—osteoporosis	0.000109	0.00447	CcSEcCtD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—IL6R—osteoporosis	0.000109	0.00464	CbGpPWpGaD
Tiludronate—Gastrointestinal pain—Ibandronate—osteoporosis	0.000109	0.00443	CcSEcCtD
Tiludronate—Myalgia—Pamidronate—osteoporosis	0.000109	0.00443	CcSEcCtD
Tiludronate—Arthralgia—Pamidronate—osteoporosis	0.000109	0.00443	CcSEcCtD
Tiludronate—Back pain—Conjugated Estrogens—osteoporosis	0.000108	0.00443	CcSEcCtD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000108	0.00459	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—TLN1—osteoporosis	0.000108	0.00457	CbGpPWpGaD
Tiludronate—Abdominal pain—Alendronate—osteoporosis	0.000108	0.0044	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—VCL—osteoporosis	0.000106	0.00451	CbGpPWpGaD
Tiludronate—Gastrointestinal pain—Calcitriol—osteoporosis	0.000106	0.00434	CcSEcCtD
Tiludronate—Abdominal pain—Raloxifene—osteoporosis	0.000106	0.00433	CcSEcCtD
Tiludronate—Abdominal pain—Ibandronate—osteoporosis	0.000105	0.00428	CcSEcCtD
Tiludronate—Vertigo—Zoledronate—osteoporosis	0.000105	0.00427	CcSEcCtD
Tiludronate—Rhinitis—Estradiol—osteoporosis	0.000103	0.00422	CcSEcCtD
Tiludronate—PTPN1—Insulin Signaling—IRS2—osteoporosis	0.000103	0.00437	CbGpPWpGaD
Tiludronate—Abdominal pain—Calcitriol—osteoporosis	0.000103	0.00419	CcSEcCtD
Tiludronate—Vertigo—Conjugated Estrogens—osteoporosis	0.000101	0.00411	CcSEcCtD
Tiludronate—Headache—Etidronic acid—osteoporosis	0.0001	0.00409	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Risedronate—osteoporosis	9.97e-05	0.00407	CcSEcCtD
Tiludronate—Asthenia—Estropipate—osteoporosis	9.94e-05	0.00405	CcSEcCtD
Tiludronate—Myalgia—Zoledronate—osteoporosis	9.91e-05	0.00405	CcSEcCtD
Tiludronate—Arthralgia—Zoledronate—osteoporosis	9.91e-05	0.00405	CcSEcCtD
Tiludronate—Asthenia—Alendronate—osteoporosis	9.79e-05	0.00399	CcSEcCtD
Tiludronate—Dyspepsia—Risedronate—osteoporosis	9.63e-05	0.00393	CcSEcCtD
Tiludronate—Myalgia—Conjugated Estrogens—osteoporosis	9.54e-05	0.00389	CcSEcCtD
Tiludronate—Arthralgia—Conjugated Estrogens—osteoporosis	9.54e-05	0.00389	CcSEcCtD
Tiludronate—Asthenia—Ibandronate—osteoporosis	9.53e-05	0.00389	CcSEcCtD
Tiludronate—Nausea—Etidronic acid—osteoporosis	9.51e-05	0.00388	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Pamidronate—osteoporosis	9.48e-05	0.00387	CcSEcCtD
Tiludronate—Diarrhoea—Estropipate—osteoporosis	9.47e-05	0.00387	CcSEcCtD
Tiludronate—Pain—Risedronate—osteoporosis	9.36e-05	0.00382	CcSEcCtD
Tiludronate—Diarrhoea—Alendronate—osteoporosis	9.33e-05	0.00381	CcSEcCtD
Tiludronate—Asthenia—Calcitriol—osteoporosis	9.33e-05	0.00381	CcSEcCtD
Tiludronate—ATP6V1A—Disease—PKM—osteoporosis	9.22e-05	0.00391	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—SOST—osteoporosis	9.22e-05	0.00391	CbGpPWpGaD
Tiludronate—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	9.18e-05	0.00375	CcSEcCtD
Tiludronate—Diarrhoea—Raloxifene—osteoporosis	9.18e-05	0.00375	CcSEcCtD
Tiludronate—Dyspepsia—Pamidronate—osteoporosis	9.16e-05	0.00374	CcSEcCtD
Tiludronate—Dizziness—Estropipate—osteoporosis	9.16e-05	0.00374	CcSEcCtD
Tiludronate—Diarrhoea—Ibandronate—osteoporosis	9.09e-05	0.00371	CcSEcCtD
Tiludronate—Dizziness—Alendronate—osteoporosis	9.02e-05	0.00368	CcSEcCtD
Tiludronate—PTPN1—Insulin Signaling—IRS1—osteoporosis	9.01e-05	0.00382	CbGpPWpGaD
Tiludronate—Gastrointestinal pain—Risedronate—osteoporosis	8.95e-05	0.00365	CcSEcCtD
Tiludronate—Pain—Pamidronate—osteoporosis	8.9e-05	0.00363	CcSEcCtD
Tiludronate—Diarrhoea—Calcitriol—osteoporosis	8.89e-05	0.00363	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—RAP1A—osteoporosis	8.89e-05	0.00377	CbGpPWpGaD
Tiludronate—Abdominal pain—Ethinyl Estradiol—osteoporosis	8.87e-05	0.00362	CcSEcCtD
Tiludronate—Dizziness—Raloxifene—osteoporosis	8.87e-05	0.00362	CcSEcCtD
Tiludronate—Dizziness—Ibandronate—osteoporosis	8.78e-05	0.00358	CcSEcCtD
Tiludronate—ATP6V1A—Disease—ANTXR2—osteoporosis	8.74e-05	0.00371	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PGLS—osteoporosis	8.74e-05	0.00371	CbGpPWpGaD
Tiludronate—Back pain—Estradiol—osteoporosis	8.68e-05	0.00354	CcSEcCtD
Tiludronate—Headache—Estropipate—osteoporosis	8.68e-05	0.00354	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Zoledronate—osteoporosis	8.66e-05	0.00353	CcSEcCtD
Tiludronate—Abdominal pain—Risedronate—osteoporosis	8.65e-05	0.00353	CcSEcCtD
Tiludronate—Headache—Alendronate—osteoporosis	8.54e-05	0.00349	CcSEcCtD
Tiludronate—Gastrointestinal pain—Pamidronate—osteoporosis	8.51e-05	0.00347	CcSEcCtD
Tiludronate—Headache—Raloxifene—osteoporosis	8.4e-05	0.00343	CcSEcCtD
Tiludronate—Dyspepsia—Zoledronate—osteoporosis	8.36e-05	0.00341	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	8.34e-05	0.0034	CcSEcCtD
Tiludronate—Headache—Ibandronate—osteoporosis	8.32e-05	0.00339	CcSEcCtD
Tiludronate—Nausea—Estropipate—osteoporosis	8.23e-05	0.00336	CcSEcCtD
Tiludronate—Abdominal pain—Pamidronate—osteoporosis	8.22e-05	0.00336	CcSEcCtD
Tiludronate—Headache—Calcitriol—osteoporosis	8.14e-05	0.00332	CcSEcCtD
Tiludronate—Pain—Zoledronate—osteoporosis	8.13e-05	0.00332	CcSEcCtD
Tiludronate—Nausea—Alendronate—osteoporosis	8.1e-05	0.00331	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—FGA—osteoporosis	8.06e-05	0.00342	CbGpPWpGaD
Tiludronate—Vertigo—Estradiol—osteoporosis	8.06e-05	0.00329	CcSEcCtD
Tiludronate—Dyspepsia—Conjugated Estrogens—osteoporosis	8.05e-05	0.00329	CcSEcCtD
Tiludronate—Asthenia—Ethinyl Estradiol—osteoporosis	8.05e-05	0.00329	CcSEcCtD
Tiludronate—Nausea—Raloxifene—osteoporosis	7.97e-05	0.00325	CcSEcCtD
Tiludronate—Nausea—Ibandronate—osteoporosis	7.89e-05	0.00322	CcSEcCtD
Tiludronate—Asthenia—Risedronate—osteoporosis	7.85e-05	0.0032	CcSEcCtD
Tiludronate—Pain—Conjugated Estrogens—osteoporosis	7.82e-05	0.00319	CcSEcCtD
Tiludronate—Gastrointestinal pain—Zoledronate—osteoporosis	7.77e-05	0.00317	CcSEcCtD
Tiludronate—Nausea—Calcitriol—osteoporosis	7.72e-05	0.00315	CcSEcCtD
Tiludronate—Diarrhoea—Ethinyl Estradiol—osteoporosis	7.68e-05	0.00313	CcSEcCtD
Tiludronate—Arthralgia—Estradiol—osteoporosis	7.64e-05	0.00312	CcSEcCtD
Tiludronate—Myalgia—Estradiol—osteoporosis	7.64e-05	0.00312	CcSEcCtD
Tiludronate—Abdominal pain—Zoledronate—osteoporosis	7.51e-05	0.00307	CcSEcCtD
Tiludronate—Diarrhoea—Risedronate—osteoporosis	7.49e-05	0.00306	CcSEcCtD
Tiludronate—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	7.48e-05	0.00305	CcSEcCtD
Tiludronate—Asthenia—Pamidronate—osteoporosis	7.46e-05	0.00305	CcSEcCtD
Tiludronate—ATP6V1A—Disease—GSN—osteoporosis	7.43e-05	0.00315	CbGpPWpGaD
Tiludronate—Dizziness—Ethinyl Estradiol—osteoporosis	7.42e-05	0.00303	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—FGB—osteoporosis	7.34e-05	0.00311	CbGpPWpGaD
Tiludronate—Dizziness—Risedronate—osteoporosis	7.24e-05	0.00295	CcSEcCtD
Tiludronate—Abdominal pain—Conjugated Estrogens—osteoporosis	7.23e-05	0.00295	CcSEcCtD
Tiludronate—Diarrhoea—Pamidronate—osteoporosis	7.12e-05	0.0029	CcSEcCtD
Tiludronate—Headache—Ethinyl Estradiol—osteoporosis	7.03e-05	0.00287	CcSEcCtD
Tiludronate—Dizziness—Pamidronate—osteoporosis	6.88e-05	0.00281	CcSEcCtD
Tiludronate—Headache—Risedronate—osteoporosis	6.86e-05	0.0028	CcSEcCtD
Tiludronate—Asthenia—Zoledronate—osteoporosis	6.82e-05	0.00278	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Estradiol—osteoporosis	6.67e-05	0.00272	CcSEcCtD
Tiludronate—Nausea—Ethinyl Estradiol—osteoporosis	6.67e-05	0.00272	CcSEcCtD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IRS2—osteoporosis	6.59e-05	0.0028	CbGpPWpGaD
Tiludronate—Asthenia—Conjugated Estrogens—osteoporosis	6.56e-05	0.00268	CcSEcCtD
Tiludronate—Headache—Pamidronate—osteoporosis	6.52e-05	0.00266	CcSEcCtD
Tiludronate—Diarrhoea—Zoledronate—osteoporosis	6.5e-05	0.00265	CcSEcCtD
Tiludronate—Nausea—Risedronate—osteoporosis	6.5e-05	0.00265	CcSEcCtD
Tiludronate—ATP6V1A—Disease—LRP5—osteoporosis	6.46e-05	0.00274	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SOST—osteoporosis	6.46e-05	0.00274	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SOST—osteoporosis	6.46e-05	0.00274	CbGpPWpGaD
Tiludronate—Dyspepsia—Estradiol—osteoporosis	6.45e-05	0.00263	CcSEcCtD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—IGF1—osteoporosis	6.44e-05	0.00273	CbGpPWpGaD
Tiludronate—Dizziness—Zoledronate—osteoporosis	6.28e-05	0.00256	CcSEcCtD
Tiludronate—Pain—Estradiol—osteoporosis	6.26e-05	0.00256	CcSEcCtD
Tiludronate—Diarrhoea—Conjugated Estrogens—osteoporosis	6.26e-05	0.00255	CcSEcCtD
Tiludronate—ATP6V1A—Disease—LRP6—osteoporosis	6.18e-05	0.00262	CbGpPWpGaD
Tiludronate—Nausea—Pamidronate—osteoporosis	6.18e-05	0.00252	CcSEcCtD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—MYC—osteoporosis	6.11e-05	0.00259	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IRAK3—osteoporosis	6.1e-05	0.00259	CbGpPWpGaD
Tiludronate—Dizziness—Conjugated Estrogens—osteoporosis	6.05e-05	0.00247	CcSEcCtD
Tiludronate—Gastrointestinal pain—Estradiol—osteoporosis	5.99e-05	0.00244	CcSEcCtD
Tiludronate—Headache—Zoledronate—osteoporosis	5.95e-05	0.00243	CcSEcCtD
Tiludronate—ATP6V1A—Disease—RPL24—osteoporosis	5.94e-05	0.00252	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—LTF—osteoporosis	5.94e-05	0.00252	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PTH1R—osteoporosis	5.84e-05	0.00248	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CALCR—osteoporosis	5.84e-05	0.00248	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CALCR—osteoporosis	5.84e-05	0.00248	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PTH1R—osteoporosis	5.84e-05	0.00248	CbGpPWpGaD
Tiludronate—Abdominal pain—Estradiol—osteoporosis	5.79e-05	0.00236	CcSEcCtD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IRS1—osteoporosis	5.76e-05	0.00244	CbGpPWpGaD
Tiludronate—Headache—Conjugated Estrogens—osteoporosis	5.73e-05	0.00234	CcSEcCtD
Tiludronate—Nausea—Zoledronate—osteoporosis	5.64e-05	0.0023	CcSEcCtD
Tiludronate—PTPN1—Immune System—ACTG1—osteoporosis	5.58e-05	0.00237	CbGpPWpGaD
Tiludronate—Nausea—Conjugated Estrogens—osteoporosis	5.43e-05	0.00222	CcSEcCtD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IL6R—osteoporosis	5.41e-05	0.00229	CbGpPWpGaD
Tiludronate—Asthenia—Estradiol—osteoporosis	5.25e-05	0.00214	CcSEcCtD
Tiludronate—ATP6V1A—Disease—ACP5—osteoporosis	5.15e-05	0.00218	CbGpPWpGaD
Tiludronate—Diarrhoea—Estradiol—osteoporosis	5.01e-05	0.00204	CcSEcCtD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—IL6—osteoporosis	4.87e-05	0.00207	CbGpPWpGaD
Tiludronate—Dizziness—Estradiol—osteoporosis	4.84e-05	0.00198	CcSEcCtD
Tiludronate—ATP6V1A—Disease—TPI1—osteoporosis	4.79e-05	0.00203	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—RAP1A—osteoporosis	4.66e-05	0.00198	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MGLL—osteoporosis	4.64e-05	0.00197	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MGLL—osteoporosis	4.64e-05	0.00197	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CTSK—osteoporosis	4.62e-05	0.00196	CbGpPWpGaD
Tiludronate—Headache—Estradiol—osteoporosis	4.59e-05	0.00187	CcSEcCtD
Tiludronate—PTPN1—Immune System—NFATC1—osteoporosis	4.55e-05	0.00193	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—LRP5—osteoporosis	4.53e-05	0.00192	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—LRP5—osteoporosis	4.53e-05	0.00192	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—P4HB—osteoporosis	4.5e-05	0.00191	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—GAPDH—osteoporosis	4.42e-05	0.00187	CbGpPWpGaD
Tiludronate—Nausea—Estradiol—osteoporosis	4.35e-05	0.00178	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—LRP6—osteoporosis	4.33e-05	0.00184	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—LRP6—osteoporosis	4.33e-05	0.00184	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—NFATC1—osteoporosis	4.2e-05	0.00178	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—DKK1—osteoporosis	4.17e-05	0.00177	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IL1B—osteoporosis	4.11e-05	0.00174	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.06e-05	0.00172	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—WNT1—osteoporosis	4.01e-05	0.0017	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—FGA—osteoporosis	3.9e-05	0.00166	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	3.86e-05	0.00164	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PSMA2—osteoporosis	3.71e-05	0.00157	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PSMA5—osteoporosis	3.71e-05	0.00157	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TLN1—osteoporosis	3.66e-05	0.00155	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TLN1—osteoporosis	3.66e-05	0.00155	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—ENO1—osteoporosis	3.48e-05	0.00148	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PSMA5—osteoporosis	3.43e-05	0.00145	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PSMA2—osteoporosis	3.43e-05	0.00145	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—IGF1—osteoporosis	3.32e-05	0.00141	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CALCA—osteoporosis	3.19e-05	0.00135	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—P4HB—osteoporosis	3.15e-05	0.00134	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—P4HB—osteoporosis	3.15e-05	0.00134	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—KL—osteoporosis	3.14e-05	0.00133	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PTH—osteoporosis	3.07e-05	0.0013	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PTH—osteoporosis	3.07e-05	0.0013	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—RAP1A—osteoporosis	3.01e-05	0.00128	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—RAP1A—osteoporosis	3.01e-05	0.00128	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CNR2—osteoporosis	2.99e-05	0.00127	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CNR2—osteoporosis	2.99e-05	0.00127	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NFATC1—osteoporosis	2.94e-05	0.00125	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NFATC1—osteoporosis	2.94e-05	0.00125	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—DKK1—osteoporosis	2.92e-05	0.00124	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—DKK1—osteoporosis	2.92e-05	0.00124	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—KL—osteoporosis	2.9e-05	0.00123	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—WNT1—osteoporosis	2.81e-05	0.00119	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—WNT1—osteoporosis	2.81e-05	0.00119	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—FGA—osteoporosis	2.73e-05	0.00116	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—FGA—osteoporosis	2.73e-05	0.00116	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PTHLH—osteoporosis	2.54e-05	0.00108	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PTHLH—osteoporosis	2.54e-05	0.00108	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—BMP2—osteoporosis	2.54e-05	0.00108	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—BMP2—osteoporosis	2.54e-05	0.00108	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—FGB—osteoporosis	2.49e-05	0.00105	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—FGB—osteoporosis	2.49e-05	0.00105	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—AGER—osteoporosis	2.47e-05	0.00105	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—ADCY5—osteoporosis	2.46e-05	0.00104	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IL6—osteoporosis	2.41e-05	0.00102	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PSMA5—osteoporosis	2.4e-05	0.00102	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PSMA2—osteoporosis	2.4e-05	0.00102	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PSMA5—osteoporosis	2.4e-05	0.00102	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PSMA2—osteoporosis	2.4e-05	0.00102	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—ADCY5—osteoporosis	2.27e-05	0.000964	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CALCA—osteoporosis	2.24e-05	0.000949	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CALCA—osteoporosis	2.24e-05	0.000949	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IRS2—osteoporosis	2.15e-05	0.000913	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MTHFR—osteoporosis	2.09e-05	0.000886	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—KL—osteoporosis	2.03e-05	0.000861	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—KL—osteoporosis	2.03e-05	0.000861	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—TGFB1—osteoporosis	1.99e-05	0.000844	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—IRS2—osteoporosis	1.99e-05	0.000843	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IRS1—osteoporosis	1.88e-05	0.000797	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IL6R—osteoporosis	1.77e-05	0.000749	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—IRS1—osteoporosis	1.74e-05	0.000736	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—IL6R—osteoporosis	1.63e-05	0.000691	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ADCY5—osteoporosis	1.59e-05	0.000675	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ADCY5—osteoporosis	1.59e-05	0.000675	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SPP1—osteoporosis	1.54e-05	0.000653	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SPP1—osteoporosis	1.54e-05	0.000653	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IRS2—osteoporosis	1.39e-05	0.00059	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IRS2—osteoporosis	1.39e-05	0.00059	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—LEP—osteoporosis	1.36e-05	0.000578	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—LEP—osteoporosis	1.36e-05	0.000578	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IL1B—osteoporosis	1.34e-05	0.00057	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ESR1—osteoporosis	1.3e-05	0.000552	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ESR1—osteoporosis	1.3e-05	0.000552	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IRS1—osteoporosis	1.22e-05	0.000515	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IRS1—osteoporosis	1.22e-05	0.000515	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—POMC—osteoporosis	1.17e-05	0.000496	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—POMC—osteoporosis	1.17e-05	0.000496	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IL6R—osteoporosis	1.14e-05	0.000484	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IL6R—osteoporosis	1.14e-05	0.000484	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IGF1—osteoporosis	1.13e-05	0.000477	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IGF1—osteoporosis	1.13e-05	0.000477	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MYC—osteoporosis	9.66e-06	0.00041	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—TGFB1—osteoporosis	9.64e-06	0.000409	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IL6—osteoporosis	7.87e-06	0.000334	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—IL6—osteoporosis	7.26e-06	0.000308	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MYC—osteoporosis	6.77e-06	0.000287	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MYC—osteoporosis	6.77e-06	0.000287	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TGFB1—osteoporosis	6.75e-06	0.000286	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TGFB1—osteoporosis	6.75e-06	0.000286	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IL6—osteoporosis	5.09e-06	0.000216	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IL6—osteoporosis	5.09e-06	0.000216	CbGpPWpGaD
